SC-101

N/A

Report date: 2025/07/17 20:00:09
NME

Base Information

Drug NameSC-101
Drug Alias NameSC-101
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionNectin-4 inhibitors
TargetsNectin-4
Therapy Area/IndicationsSolid tumoursTriple Negative Breast NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTianjin Conjustar Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTianjin Conjustar Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursTriple Negative Breast NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A